Aurion Biotech Appoints World Renowned Cornea Surgeon Marjan Farid, M.D., to Chair Medical Advisory Board

2026-03-11 - 11:03

SEATTLE & CAMBRIDGE, Mass. & TOKYO -- Aurion Biotech, Inc. (“Aurion”), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced the appointment of Dr. Marjan Farid of the Gavin Herbert Eye Institute at the University of California-Irvine (UCI) as Chair of Aurion Biotech’s medical advisory board (MAB). Dr. Farid is a distinguished cornea, cataract and refractive surgeon, a global educator and researcher, and Chair of the Cornea Clinical Committee of the American Society of Cataract and Refractive Surgery (ASCRS). Read More